4 results
-
List item
Human medicine European public assessment report (EPAR): BiResp Spiromax
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021 -
List item
Human medicine European public assessment report (EPAR): DuoResp Spiromax
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021 -
List item
Referral: Inhaled corticosteroids containing medicinal products indicated in the treatment of chronic obstructive pulmonary disease
beclometasone, budesonide, flunisolide, fluticasone propionate, fluticasone furoate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 28/04/2016, EC decision date: 29/06/2016, Last updated: 15/07/2016 -
List item
Public data from Article 57 database
Last updated: 17/10/2022